UnicoCell Biomed Balance Sheet Health
Financial Health criteria checks 6/6
UnicoCell Biomed has a total shareholder equity of NT$565.1M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$655.2M and NT$90.1M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | n/a |
| Cash | NT$456.14m |
| Equity | NT$565.13m |
| Total liabilities | NT$90.09m |
| Total assets | NT$655.22m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 6794's short term assets (NT$484.1M) exceed its short term liabilities (NT$19.0M).
Long Term Liabilities: 6794's short term assets (NT$484.1M) exceed its long term liabilities (NT$71.0M).
Debt to Equity History and Analysis
Debt Level: 6794 is debt free.
Reducing Debt: 6794 has no debt compared to 5 years ago when its debt to equity ratio was 4%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6794 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 6794 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 5.3% each year